| Title |
SARS-CoV-2 and the Use of Chloroquine as an Antiviral Treatment
|
|---|---|
| Published in |
Frontiers in Medicine, April 2020
|
| DOI | 10.3389/fmed.2020.00184 |
| Pubmed ID | |
| Authors |
Mathieu E. Rebeaud, Florian Zores |
X Demographics
The data shown below were collected from the profiles of 102 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| France | 32 | 31% |
| United States | 7 | 7% |
| Canada | 4 | 4% |
| Belgium | 2 | 2% |
| Switzerland | 2 | 2% |
| Russia | 1 | <1% |
| Mauritius | 1 | <1% |
| Germany | 1 | <1% |
| Madagascar | 1 | <1% |
| Other | 2 | 2% |
| Unknown | 49 | 48% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 95 | 93% |
| Scientists | 5 | 5% |
| Science communicators (journalists, bloggers, editors) | 1 | <1% |
| Practitioners (doctors, other healthcare professionals) | 1 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 109 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 109 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 12 | 11% |
| Researcher | 10 | 9% |
| Student > Master | 10 | 9% |
| Student > Doctoral Student | 9 | 8% |
| Other | 8 | 7% |
| Other | 25 | 23% |
| Unknown | 35 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 26 | 24% |
| Biochemistry, Genetics and Molecular Biology | 10 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 6% |
| Agricultural and Biological Sciences | 4 | 4% |
| Social Sciences | 4 | 4% |
| Other | 17 | 16% |
| Unknown | 41 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 77. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 December 2023.
All research outputs
#560,025
of 25,571,620 outputs
Outputs from Frontiers in Medicine
#169
of 7,251 outputs
Outputs of similar age
#17,127
of 406,346 outputs
Outputs of similar age from Frontiers in Medicine
#12
of 131 outputs
Altmetric has tracked 25,571,620 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,251 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.6. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 406,346 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 131 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.